Sign in

Doctors welcome move to prescribe generic drugs, say accessibility may be an issue

Updated on: Apr 18, 2017, 07:24:10 IST
New Delhi | By
Share
Share via
  • facebook
  • twitter
  • linkedin
  • whatsapp
Copy link
  • copy link
The Medical Council of India already has a recommendation in place wherein they have asked doctors to preferably prescribe generic drugs. (Shutterstock)
The Medical Council of India already has a recommendation in place wherein they have asked doctors to preferably prescribe generic drugs. (Shutterstock)

Prescribing a generic medicine means doctors are supposed to write the name of the salt and not the brand name under which the salt is manufactured and marketed.

While on the one hand Prime Minister Narendra Modi’s announcement to bring in a law to compel doctors to prescribe generic drugs is being hailed by the medical fraternity, on the other hand access to these drugs is a matter of concern.

“It is a good thing and will benefit patients a lot as they will be getting life-saving drugs at a much cheaper rates,” says Dr KK Talwar, former director, PGI Chandigarh and head of cardiology at Max Healthcare.

The Medical Council of India (MCI), an apex body that supervises medical education in the country, already has a recommendation in place wherein they have asked doctors to preferably prescribe generic drugs.

“It is not as if we don’t prescribe generic drugs; in fact one-third of the medicines that I prescribe are generic medicines, but currently accessibility and quality of these drugs is an issue,” says Dr Talwar.

Prescribing a generic medicine means doctors are supposed to write the name of the salt and not the brand name under which the salt is manufactured and marketed.

“We do not even write the brand name of the generic drug as it defeats the purpose. Why should I be prescribing one brand of generic medicine and not the other, which is why we just write the salt name,” says a senior doctor at All India Institute of Medical Sciences (AIIMS), Delhi, requesting anonymity.

The problem, however, is that there are not enough outlets selling generic drugs.

“Though things are improving, there is still a lot that the field requires. We have some companies producing generic drugs and we export these medicines, too, but most of the shops selling these medicines are not well stocked,” says the AIIMS doctor.

Assuring better quality is equally important.

The problem, say doctors, is that there are not enough outlets selling generic drugs. (Shutterstock)
The problem, say doctors, is that there are not enough outlets selling generic drugs. (Shutterstock)

“Promoting generic industry is good but we should not just produce generic drugs but also produce quality generic drugs as it is a matter of people’s lives. The government should a proper monitoring mechanism in place for the production quality of these drugs,” says Dr Talwar.

Also, another crucial factor is some of the new salts are patented that cannot be produced by generic drug makers.

“There are certain new drugs that are patented and cannot be manufactured for a certain number of years such as heart or cancer medicines but old salts can definitely be manufactured to benefit patients at large,” says Dr Talwar.

Follow @htlifeandstyle for more.

  • Rhythma Kaul
    ABOUT THE AUTHOR
    Rhythma Kaul

    Rhythma Kaul is the national health editor of the Hindustan Times. She has been reporting on public health, medicine, and medical research, with a particular focus on how government decisions and health system reforms shape people’s lives. Rhythma has over 25 years of journalistic experience. She joined Hindustan Times in 2008, and has since covered everything from pandemics and infectious diseases to cutting‑edge medical research and climate‑related health challenges. Her stories routinely track the work of the Ministry of Health and Family Welfare, department of pharmaceuticals, and key national health programmes, making complex medical science and policy accessible to a wide audience. One of her prominent news breaks has been the 2012 Baby Falak case: A two-year-old brutally battered baby girl was admitted to AIIMS-Delhi with severe head injuries, multiple fractures, human bite marks, and burns. The police investigation revealed this to be a case of multi-state human-trafficking racket. She was profiled by The Wall Street Journal for breaking this story. Rhythma holds a Master’s degree from Jawaharlal Nehru University, Delhi. Prior to Hindustan Times, she worked with the India Today Group. Rhythma can be contacted at rhythma.kaul@hindustantimes.com. Her X handle is @RamblingBrook.Read More

Catch every big hit, every wicket with Crick-it, a one stop destination for Live Scores, Match Stats, Quizzes, Polls & much more. Explore now!.

Catch your daily dose of Fashion, Taylor Swift, Health, Festivals, Travel, Relationship, Recipe and all the other Latest Lifestyle News on Hindustan Times Website and APPs.